We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News
RSNA 2022
Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

MRI Identifies Patients at Higher Risk for Cardiac Sarcoidosis-Related Adverse Outcomes

By MedImaging International staff writers
Posted on 05 Oct 2022

Cardiac sarcoidosis is a rare inflammatory heart disease that can result in rhythm disturbances and heart failure. Researchers have now found that patients with certain features on magnetic resonance imaging (MRI) of the heart are at much higher risk for cardiac sarcoidosis-related adverse outcomes. These patients may benefit from an implantable cardioverter defibrillator. Meanwhile, other features identified patients at very low risk who might not benefit from the device.

In this largest study yet of suspected cardiac sarcoidosis investigated by cardiac MRI, the researchers from the University of Minnesota Medical School (Minneapolis, MN, USA) studied 504 patients. The MRI features were based on the research team’s previously published study that described features of cardiac damage in the hearts of patients with cardiac sarcoidosis who had suddenly died or needed heart transplantation. Researchers note that these findings should be replicated in other, more diverse, cohorts. Whether clinical management guided by these cardiac MRI features improves outcomes in patients with suspected cardiac sarcoidosis should be prospectively tested in a randomized trial.


Image: MRI identifies patients with sarcoidosis at risk for bad cardiac outcomes (Photo courtesy of University of Minnesota Medical School)
Image: MRI identifies patients with sarcoidosis at risk for bad cardiac outcomes (Photo courtesy of University of Minnesota Medical School)

“Late gadolinium enhancement on cardiovascular magnetic resonance imaging is often used to diagnose cardiac sarcoidosis. Our research shows that not all patients with late gadolinium enhancement on cardiac MRI have the same risk of adverse outcomes, particularly ventricular arrhythmias,” said Chetan Shenoy, MBBS, MS, an associate professor of medicine at the University of Minnesota Medical School and the lead author of the study. “We believe our findings will help optimize the clinical care of patients with suspected cardiac sarcoidosis, and consequently, lead to better outcomes.”

Related Links:
University of Minnesota Medical School


Gold Supplier
Ultrasound Transducer/Probe Cleaner
Transeptic Cleaning Solution
New
Ultrasound System
MyLab X1
New
Ultrasound System
Xario 200G
New
Silver Supplier
Pocket-Size Fetal Doppler
BT-220220C/BT-220L

Latest MRI News